Cynapsus Therapeutics Inc. (“Cynapsus”) (NASDAQ: CYNA) announced that at its special meeting of shareholders and warrantholders (collectively, the “Securityholders”) held ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE